Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OncoGel adjunctive chemoradiotherapy before surgery in localized or loco-regional esophageal cancer
2007-005051-42Phase 2Completed
- Sponsor
- Protherics PLC
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in esophageal cancer (2 arms), sponsored by Protherics PLC. Primary endpoint: Overall tumor response at the primary tumor site. Started Jan 2008; status: completed.
02
Drugs
paclitaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2007-005051-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005051-42.